The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
Akers Biosciences announced Premas Biotech, its partner in the development of a vaccine candidate that is seeking to address the COVID-19 pandemic, ...
read more
Blueprint Medicines announced the FDA has issued a CRL for the new drug application of avapritinib for unresectable or metastatic fourth-line ...
read more
Review the latest news and information on the Coronavirus Pandemic.
read more
Janssen Research & Development
Janssen announced results from the Phase 1 CHRYSALIS study evaluating amivantamab in the treatment of patients with advanced NSCLC with EGFR Exon 20 ...
read more
Review the latest news and information on the Coronavirus Pandemic.
read more
Oculis has reported positive results from its study of OCS-01, a novel, high concentration, preservative free, topical SNP formulation of ...
read more
AstraZeneca Pharmaceuticals
AstraZeneca and Daiichi Sankyo’s Enhertu has been granted BTD in the US for the treatment of patients with metastatic NSCLC.
read more
Heron has initiated a Phase 1b/2 clinical study in patients undergoing bunionectomy of HTX-034 for the treatment of postoperative pain.
read more
AstraZeneca Pharmaceuticals
Bevespi Aerosphere has been approved in China as a maintenance treatment to relieve symptoms in patients with COPD including chronic bronchitis and/or...
read more
AveXis announced EC granted conditional approval for Zolgensma for the treatment of patients with 5q spinal muscular atrophy.
read more
Arch Biopartners has expanded the primary endpoint of the trial for its lead drug LSALT peptide to prevent organ inflammation and injury experienced ...
read more
Fate announced the FDA has cleared the Company’s IND application for FT538, the first CRISPR-edited, iPSC-derived cell therapy.
read more
Progenabiome is starting two FDA-approved clinical trials that include hydroxychloroquine.
read more
Cipla has received final approval for its ANDA for Dihydroergotamine Mesylate Nasal Spray 4mg/mL from the FDA with a Competitive Generic Therapy ...
read more
Apellis announced plans to submit a NDA for pegcetacoplan for the treatment of paroxysmal nocturnal hemoglobinuria in the second half of 2020.
read more